triptorelin
Term · Oncology and biomedicine · MLC-T-ONC-017331
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.
| Identifier | MLC-T-ONC-017331 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 6-D-tryptophan-LH-RH; 6-D-tryptophanluteinizing hormone-releasing factor; detryptoreline |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017331",
"term": "triptorelin",
"field": "Oncology and biomedicine",
"definition": "A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.",
"synonyms": [
"6-D-tryptophan-LH-RH",
"6-D-tryptophanluteinizing hormone-releasing factor",
"detryptoreline"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/triptorelin/"
}
Record 16,736 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.